 | • レポートコード：QYR9NV18020 • 出版社/出版日：QYResearch / 2019年11月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、免疫性血小板減少薬の世界市場について調査・分析し、免疫性血小板減少薬の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（トロンボポエチン受容体作動薬（TPO-RA）、コルチコステロイド、静脈内免疫グロブリン（IVIG）、その他薬物）、用途別（バイオテクノロジー及び製薬会社、病院及び診断センター、学術機関及び研究機関）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の免疫性血小板減少薬市場動向 ・主要企業別マーケットシェア ・免疫性血小板減少薬の種類別市場規模2014-2019 （トロンボポエチン受容体作動薬（TPO-RA）、コルチコステロイド、静脈内免疫グロブリン（IVIG）、その他薬物） ・免疫性血小板減少薬の用途別市場規模2014-2019 （バイオテクノロジー及び製薬会社、病院及び診断センター、学術機関及び研究機関） ・免疫性血小板減少薬の北米市場：主要企業・種類別/用途別市場規模 ・免疫性血小板減少薬のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・免疫性血小板減少薬の中国市場：主要企業・種類別/用途別市場規模 ・免疫性血小板減少薬の日本国内市場：主要企業・種類別/用途別市場規模 ・免疫性血小板減少薬の東南アジア市場：主要企業・種類別/用途別市場規模 ・免疫性血小板減少薬のインド市場：主要企業・種類別/用途別市場規模 ・免疫性血小板減少薬の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Amgen Inc.、CSL Ltd.、Horizon Therapeutics Plc、Merck & Co., Inc.、Novartis AG、Rigel Pharmaceuticals Inc.） ・免疫性血小板減少薬の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Thrombocytopenia is a condition characterized by abnormally low levels of thrombocytes, also known as platelets, in the blood.End-users prefer biosimilars over biologics because of their low cost. The low cost of biosimilars can be attributed to the fewer number of clinical trials required for approval. The upcoming expiration of patents in the immune thrombocytopenia drugs market will fuel the development of biosimilars for those products. For instance, the forthcoming expiration of patents of Nplate (romiplostim) and rituximab has encouraged market vendors to develop their biosimilars. This will also create several opportunities for new vendors to enter the market. Hence, the growing popularity and development of biosimilars will augment the growth of the immune thrombocytopenia drugs market throughout the next five years.
In 2018, the global Immune Thrombocytopenia Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Immune Thrombocytopenia Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immune Thrombocytopenia Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Amgen Inc.
CSL Ltd.
Horizon Therapeutics Plc
Merck & Co., Inc.
Novartis AG
Rigel Pharmaceuticals Inc.
…
Market segment by Type, the product can be split into
Thrombopoietin Receptor Agonists (TPO-RAs)
Corticosteroids
Intravenous Immunoglobins (IVIGs)
Other Drugs
Market segment by Application, split into
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostic Centers
Academic Institutes and Research Organizations
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Immune Thrombocytopenia Drugs status, future forecast, growth opportunity, key market and key players.
To present the Immune Thrombocytopenia Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Immune Thrombocytopenia Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Immune Thrombocytopenia Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Thrombopoietin Receptor Agonists (TPO-RAs)
1.4.3 Corticosteroids
1.4.4 Intravenous Immunoglobins (IVIGs)
1.4.5 Other Drugs
1.5 Market by Application
1.5.1 Global Immune Thrombocytopenia Drugs Market Share by Application (2019-2025)
1.5.2 Biotechnology and Pharmaceutical Companies
1.5.3 Hospitals and Diagnostic Centers
1.5.4 Academic Institutes and Research Organizations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Immune Thrombocytopenia Drugs Market Size
2.2 Immune Thrombocytopenia Drugs Growth Trends by Regions
2.2.1 Immune Thrombocytopenia Drugs Market Size by Regions (2019-2025)
2.2.2 Immune Thrombocytopenia Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
3.1 Immune Thrombocytopenia Drugs Market Size by by Players
3.1.1 Global Immune Thrombocytopenia Drugs Revenue by by Players (2014-2019)
3.1.2 Global Immune Thrombocytopenia Drugs Revenue Market Share by by Players (2014-2019)
3.1.3 Global Immune Thrombocytopenia Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Immune Thrombocytopenia Drugs Key Players Head office and Area Served
3.3 Key Players Immune Thrombocytopenia Drugs Product/Solution/Service
3.4 Date of Enter into Immune Thrombocytopenia Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Immune Thrombocytopenia Drugs Market Size by Type (2014-2019)
4.2 Global Immune Thrombocytopenia Drugs Market Size by Application (2014-2019)
5 North America
5.1 North America Immune Thrombocytopenia Drugs Market Size (2014-2019)
5.2 Immune Thrombocytopenia Drugs Key Players in North America
5.3 North America Immune Thrombocytopenia Drugs Market Size by Type
5.4 North America Immune Thrombocytopenia Drugs Market Size by Application
6 Europe
6.1 Europe Immune Thrombocytopenia Drugs Market Size (2014-2019)
6.2 Immune Thrombocytopenia Drugs Key Players in Europe
6.3 Europe Immune Thrombocytopenia Drugs Market Size by Type
6.4 Europe Immune Thrombocytopenia Drugs Market Size by Application
7 China
7.1 China Immune Thrombocytopenia Drugs Market Size (2014-2019)
7.2 Immune Thrombocytopenia Drugs Key Players in China
7.3 China Immune Thrombocytopenia Drugs Market Size by Type
7.4 China Immune Thrombocytopenia Drugs Market Size by Application
8 Japan
8.1 Japan Immune Thrombocytopenia Drugs Market Size (2014-2019)
8.2 Immune Thrombocytopenia Drugs Key Players in Japan
8.3 Japan Immune Thrombocytopenia Drugs Market Size by Type
8.4 Japan Immune Thrombocytopenia Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Immune Thrombocytopenia Drugs Market Size (2014-2019)
9.2 Immune Thrombocytopenia Drugs Key Players in Southeast Asia
9.3 Southeast Asia Immune Thrombocytopenia Drugs Market Size by Type
9.4 Southeast Asia Immune Thrombocytopenia Drugs Market Size by Application
10 India
10.1 India Immune Thrombocytopenia Drugs Market Size (2014-2019)
10.2 Immune Thrombocytopenia Drugs Key Players in India
10.3 India Immune Thrombocytopenia Drugs Market Size by Type
10.4 India Immune Thrombocytopenia Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Immune Thrombocytopenia Drugs Market Size (2014-2019)
11.2 Immune Thrombocytopenia Drugs Key Players in Central & South America
11.3 Central & South America Immune Thrombocytopenia Drugs Market Size by Type
11.4 Central & South America Immune Thrombocytopenia Drugs Market Size by Application
12 International Players Profiles
12.1 Amgen Inc.
12.1.1 Amgen Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Immune Thrombocytopenia Drugs Introduction
12.1.4 Amgen Inc. Revenue in Immune Thrombocytopenia Drugs Business (2014-2019))
12.1.5 Amgen Inc. Recent Development
12.2 CSL Ltd.
12.2.1 CSL Ltd. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Immune Thrombocytopenia Drugs Introduction
12.2.4 CSL Ltd. Revenue in Immune Thrombocytopenia Drugs Business (2014-2019)
12.2.5 CSL Ltd. Recent Development
12.3 Horizon Therapeutics Plc
12.3.1 Horizon Therapeutics Plc Company Details
12.3.2 Company Description and Business Overview
12.3.3 Immune Thrombocytopenia Drugs Introduction
12.3.4 Horizon Therapeutics Plc Revenue in Immune Thrombocytopenia Drugs Business (2014-2019)
12.3.5 Horizon Therapeutics Plc Recent Development
12.4 Merck & Co., Inc.
12.4.1 Merck & Co., Inc. Company Details
12.4.2 Company Description and Business Overview
12.4.3 Immune Thrombocytopenia Drugs Introduction
12.4.4 Merck & Co., Inc. Revenue in Immune Thrombocytopenia Drugs Business (2014-2019)
12.4.5 Merck & Co., Inc. Recent Development
12.5 Novartis AG
12.5.1 Novartis AG Company Details
12.5.2 Company Description and Business Overview
12.5.3 Immune Thrombocytopenia Drugs Introduction
12.5.4 Novartis AG Revenue in Immune Thrombocytopenia Drugs Business (2014-2019)
12.5.5 Novartis AG Recent Development
12.6 Rigel Pharmaceuticals Inc.
12.6.1 Rigel Pharmaceuticals Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Immune Thrombocytopenia Drugs Introduction
12.6.4 Rigel Pharmaceuticals Inc. Revenue in Immune Thrombocytopenia Drugs Business (2014-2019)
12.6.5 Rigel Pharmaceuticals Inc. Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Immune Thrombocytopenia Drugs Key Market Segments
Table Key Players Immune Thrombocytopenia Drugs Covered
Table Global Immune Thrombocytopenia Drugs Market Size Growth Rate by Type 2018-2025 (Million US$)
Figuer Thrombopoietin Receptor Agonists (TPO-RAs) Figures
Table Key Players of Thrombopoietin Receptor Agonists (TPO-RAs)
Figuer Corticosteroids Figures
Table Key Players of Corticosteroids
Figuer Intravenous Immunoglobins (IVIGs) Figures
Table Key Players of Intravenous Immunoglobins (IVIGs)
Figuer Other Drugs Figures
Table Key Players of Other Drugs
Table Global Immune Thrombocytopenia Drugs Market Size Growth by Application 2019-2025 (Million US$)
Figure Global Immune Thrombocytopenia Drugs Market Share by Application in 2018 & 2025
Figure Biotechnology and Pharmaceutical Companies Case Studies
Figure Hospitals and Diagnostic Centers Case Studies
Figure Academic Institutes and Research Organizations Case Studies
Figure Immune Thrombocytopenia Drugs Report Years Considered
Figure Global Immune Thrombocytopenia Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Immune Thrombocytopenia Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Immune Thrombocytopenia Drugs Market Size by Regions 2019-2025 (Million US$)
Table Global Immune Thrombocytopenia Drugs Market Share by Regions 2014-2019
Figure Global Immune Thrombocytopenia Drugs Market Share by Regions 2014-2019
Figure Global Immune Thrombocytopenia Drugs Market Share by Regions in 2018
Table Market Top Trends
Table Key Drivers: Impact Analysis (2019-2025)
Table Key Challenges
Figure PORTER'S FIVE FORCES ANALYSIS
Table Global Immune Thrombocytopenia Drugs Revenue by by Players (2014-2019) (Million US$)
Table Global Immune Thrombocytopenia Drugs Market Share by by Players (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Market Share by by Players in 2018
Table Global Immune Thrombocytopenia Drugs by Players Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Immune Thrombocytopenia Drugs Product/Solution/Service
Table Date of Enter into Immune Thrombocytopenia Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Immune Thrombocytopenia Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Immune Thrombocytopenia Drugs Market Size Share by Type (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Market Size Market Share by Type (2014-2019)
Table Global Immune Thrombocytopenia Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Immune Thrombocytopenia Drugs Market Size Share by Application (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Market Size Market Share by Application (2014-2019)
Figure Global Immune Thrombocytopenia Drugs Revenue Market Share by Application in 2018
Figure North America Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table North America Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table North America Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table North America Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table North America Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table North America Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table North America Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Figure Europe Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table Europe Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table Europe Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table Europe Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table Europe Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Figure China Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table China Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table China Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table China Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table China Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Figure Japan Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table Japan Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table Japan Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table Japan Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table Japan Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Figure Southeast Asia Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table Southeast Asia Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table Southeast Asia Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table Southeast Asia Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table Southeast Asia Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Figure India Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table India Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table India Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table India Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table India Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Figure Central & South America Immune Thrombocytopenia Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Immune Thrombocytopenia Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Immune Thrombocytopenia Drugs Market Share (2018-2019)
Table Central & South America Immune Thrombocytopenia Drugs Market Size by Type 2014-2019 (Million US$)
Table Central & South America Immune Thrombocytopenia Drugs Market Share by Type 2014-2019
Table Central & South America Immune Thrombocytopenia Drugs Market Size by Application 2014-2019 (Million US$)
Table Central & South America Immune Thrombocytopenia Drugs Market Share by Application 2014-2019
Table Amgen Inc. Company Details
Table Amgen Inc. Revenue in Immune Thrombocytopenia Drugs Business 2014-2019 (Million US$)
Figure Amgen Inc. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2014-2019)
Table Amgen Inc. Recent Development
Table CSL Ltd. Company Details
Table CSL Ltd. Revenue in Immune Thrombocytopenia Drugs Business 2014-2019 (Million US$)
Figure CSL Ltd. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2014-2019)
Table CSL Ltd. Recent Development
Table Horizon Therapeutics Plc Company Details
Table Horizon Therapeutics Plc Revenue in Immune Thrombocytopenia Drugs Business 2014-2019 (Million US$)
Figure Horizon Therapeutics Plc Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2014-2019)
Table Horizon Therapeutics Plc Recent Development
Table Merck & Co., Inc. Company Details
Table Merck & Co., Inc. Revenue in Immune Thrombocytopenia Drugs Business 2014-2019 (Million US$)
Figure Merck & Co., Inc. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2014-2019)
Table Merck & Co., Inc. Recent Development
Table Novartis AG Company Details
Table Novartis AG Revenue in Immune Thrombocytopenia Drugs Business 2014-2019 (Million US$)
Figure Novartis AG Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2014-2019)
Table Novartis AG Recent Development
Table Rigel Pharmaceuticals Inc. Company Details
Table Rigel Pharmaceuticals Inc. Revenue in Immune Thrombocytopenia Drugs Business 2014-2019 (Million US$)
Figure Rigel Pharmaceuticals Inc. Revenue Growth Rate in Immune Thrombocytopenia Drugs Business (2014-2019)
Table Rigel Pharmaceuticals Inc. Recent Development
Table Global Immune Thrombocytopenia Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Immune Thrombocytopenia Drugs Market Size Share by Regions (2019-2025)
Figure Global Immune Thrombocytopenia Drugs Market Size Share by Regions in 2025
Figure North America Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Immune Thrombocytopenia Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Immune Thrombocytopenia Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Immune Thrombocytopenia Drugs Market Size by Product (2019-2025)
Figure Global Immune Thrombocytopenia Drugs Market Size by Product in 2025
Table Global Immune Thrombocytopenia Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Immune Thrombocytopenia Drugs Market Size by Application (2019-2025)
Figure Global Immune Thrombocytopenia Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
免疫性血小板減少薬のグローバル市場：規模・現状・予測2019-2025 Thrombocytopenia is a condition characterized by abnormally low levels of thrombocytes, also known as platelets, in the blood.End-users prefer biosimilars over biologics because of their low cost. The low cost of biosimilars can be attributed to the fewer number of clinical trials required for appro…- 免疫性血小板減少薬のグローバル市場：規模・現状・予測2019-2025 Thrombocytopenia is a condition characterized by abnormally low levels of thrombocytes, also known as platelets, in the blood.End-users prefer biosimilars over biologics because of their low cost. The low cost of biosimilars can be attributed to the fewer number of clinical trials required for appro…
- 重症筋無力症薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Acetylcholine esterase (AChE) inhibitors are considered to be the basic treatment of myasthenia gravis (MG). Edrophonium is primarily used as a diagnostic tool owing to its short half-life. Pyridostigmine is used for long-term maintenance. Scope of the Report: This report focuses on the Myasthenia G…
- 鼻ポリープ薬のグローバル市場：規模・現状・予測2019-2025 Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occ…
- 鼻ポリープ薬のグローバル市場：規模・現状・予測2019-2025 Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occ…